Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Recruiting · NCT06684327 · Registry updated 2024-12-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors | Genital Diseases, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, bladder urachal carcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, extramammary Paget disease, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, myomatous neoplasm, neoplasm, penile cancer, penile disorder, penile neoplasm, rhabdomyosarcoma, sarcoma, testicular cancer, testicular disorder | Recruiting | Phase 2 | 2024-12-20 | NCT06684327 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Cancer Hospital | Shanghai | China | 5 |